Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01134913 · ClinicalTrials.gov registry record
Multi-Markers In the Diagnosis of Acute Coronary Syndrome
A clinical trial, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 621
- Enrollment target
NCT01134913: Completed study, sponsored by Abbott RDx Cardiometabolic.
NCT01134913 is a clinical trial that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 621 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01134913 has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 621 participants
- Enrollment target
Study Summary
This is a prospective clinical study designed to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome). Subjects enrolled in this study will sign and informed consent and have 4 blood samples drawn at different time points during their emergency department visit. In addition, data will be collected about the patient's health history, hospital procedures, and final diagnosis. The enrolling center will also contact the patients at 30-days, 3 months and 6 months to inquire about their condition and survival. Blood samples collected in this study will be sent to the sponsor organization for long-term storage and analysis in the future for novel blood markers as they become available. No genetic testing will be conducted on these samples.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 621 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-12 |
What the finished NCT01134913 record still lists
NCT01134913 is an observational study that tracks outcomes without assigning an intervention. The registered 621 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01134913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01134913 about?
NCT01134913 is a clinical study titled "Multi-Markers In the Diagnosis of Acute Coronary Syndrome". This is a prospective clinical study designed to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome). Subjects enrolled in this study will sign and informed consent and have 4 blood samples drawn at different time points during th...
What is the current status of trial NCT01134913?
This trial is currently completed. The enrollment target is 621 participants. The study started on 2010-03. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01134913?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712355 · 621 participants · Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- NCT02282969 · 620 participants
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- NCT02838836 · 620 participants
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- NCT05538910 · 620 participants · NA
Defining Neurobiological Links Between Substance Use and Mental Illness
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia